Publications

Clinical Trial
Clinical Trial, Phase II Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't
Ppublish 155 citations
Electronic publication date
March 3, 1999

View on Pubmed.gov 10052405 | View on doi.org 10.1001/archder...

Interleukin 10 treatment of psoriasis: clinical results of a phase 2 trial.

Search for publications in this journal Arch Dermatol - 135(2):187-92

Abstract

OBJECTIVE

To determine the safety and clinical effects of interleukin 10 (IL-10) treatment of psoriasis.

DESIGN AND METHODS

In an open-label phase 2 trial, 10 patients with psoriasis subcutaneously received recombinant human IL-10 over a 7-week period in a dosage of 8 microg/kg daily (n=5) or 20 microg/kg 3 times per week (n=5). Patients were followed up for an additional 5 weeks.

RESULTS

The treatment was well tolerated. Antipsoriatic effects were found in all but 1 patient. A significant decrease of the psoriasis area and severity index by 55.3% +/- 11.5% (mean +/- SEM) was observed (P<.02). The antipsoriatic efficiency was confirmed by histological examination. Heterogeneity in the effectiveness was found among the patients, but seems to be independent of the dosage regimen. However, a tendency to a better response was found in the patients who received 20-microg/kg IL-10 3 times per week. Decreasing response in the delayed-type hypersensitivity reaction against recall antigens indicated immunosuppressive effects. Moderate effects on hematopoietic cells were observed.

CONCLUSIONS

Our data suggest that IL-10 therapy for psoriasis is safe and possibly clinically effective. Consequently, its value in psoriasis and similar immune diseases should be further determined. Dose-finding, placebo-controlled, double-blind trials are necessary now.

References

No references provided.

Cited by 155 citations (total)

Journal Article Review

The immunologic effects of estrogen on psoriasis: A comprehensive review.

Electronic publication date May 14, 2015

Search for publications in this journal Int J Womens Dermatol

Melissa Danesh [...] Jenny E Murase et al.

BACKGROUND

Immunological changes in pregnancy are associated with improvements in some pre-existing immune-mediated skin diseases. Estrogen has been hypothesized to contribute...

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection.

Electronic publication date November 26, 2002

Search for publications in this journal Infect Immun

Sanbao Ruan [...] Judd E Shellito et al.

The relationship between tissue inflammation and clearance of the opportunistic pathogen Pneumocystis carinii is poorly understood. We asked whether the...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances